Navigation Links
European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
Date:9/24/2007

who fail to achieve an early response can have their therapy stopped with confidence."

In the study, failure to prior therapy was defined as relapse or non- response to one or more courses of interferon alpha plus ribavirin combination therapy (HCV-RNA positive at the end of a minimum of 12 weeks of treatment). Patients who were HCV-RNA negative at treatment week 12 continued treatment for a total of 48 weeks and were followed for 24 weeks post-treatment.

Based on results from this clinical study, the recommended duration of dosing with PEGINTRON combination therapy for retreating patients who failed previous therapy and who have undetectable virus at week 12 is 48 weeks, regardless of HCV genotype.

PEGINTRON in the European Union

PEGINTRON and REBETOL combination therapy for chronic hepatitis C was approved in the EU in March 2001. The recommended dose in the EU for combination therapy is PEGINTRON 1.5 mcg/kg once weekly plus REBETOL 800-1,400 mg daily, adjusted to body weight. The recommended duration of treatment is 24 weeks for naive patients with HCV genotype 1 and low viral load, or HCV genotype 2 or 3. The recommended duration of treatment is 48 weeks for naive patients with HCV genotype 1 and high viral load, HCV genotype 4 or HIV coinfection regardless of HCV genotype. PEGINTRON had previously received centralized marketing authorization in the EU and is marketed as a monotherapy in cases of intolerance or contraindication to ribavirin for the treatment of adult patients with chronic hepatitis C.

Chronic hepatitis C is estimated to affect more than 10 million people in major world markets, including 5 million in Europe. It is a leading cause of chronic liver disease and one of the most common reasons for liver transplant in Europe.

PEGINTRON in the United States

In the United States, PEGINTRON is indicated for use alone or with ribavirin for the treatment of chronic hepatitis C in patients with compensated liver di
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. Malvern initiates European user group meetings for chemical imaging
7. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
8. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
9. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
10. Inspire Announces Presentations at Two European Scientific Conferences
11. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013   Life Technologies Corporation ... its Applied Biosystems™ 3500 Dx and 3500xL Dx Genetic ... Protection against Health Risks in Mexico ... extension of Life Technologies, capabilities to serve the clinical ... with Sanger -based solutions.  ...
(Date:5/20/2013)... -- TNI BioTech, Inc. (OTCQB: TNIB), a biotech company combating ... body,s immune system using patented immunotherapy, announced its common stock ... the ticker symbol "TNIB" commencing May 17, 2013. Investors will ... quotes for TNIB at http://www.otcmarkets.com/stock/TNIB/quote . ... BioTech, Inc. stated, "We are very pleased to provide ...
(Date:5/20/2013)... 20, 2013 Decision Resources, one of ... pharmaceutical and healthcare issues, finds that surveyed U.S. ... greater effect on quality of life is among ... high level of subjectivity and variability of tests ... leaders state that it is difficult to differentiate ...
Breaking Medicine Technology:Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 2TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 3For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2
(Date:5/20/2013)... The automated external defibrillator market ... categories - semi-automated and fully automated defibrillators. Based ... categories, namely, hospitals, pre-hospital, public access, alternate care, ... Automated external defibrillators play an important role in ... Considering the life-saving potential of AEDs, legislations requiring ...
(Date:5/20/2013)... Recent environmental concerns have helped ... and sustainable inputs in packaging products. As such, ... promote the use of sustainable materials, thereby driving ... industry . “Tax subsidies and operating cost savings ... analyst Deonta Smith. “For example, many packaging product ...
(Date:5/20/2013)... In order to prepare for the long hot ... DrSmartphoneMD launched an article series to raise awareness about skincare ... launched with the precautions that need to be taken ... are not one of the 3.5 million cases of skin ... of all skin cancer cases are associated with exposure to ...
(Date:5/20/2013)... Parker Waichman LLP, a national law firm ... defective drugs, has filed a lawsuit on behalf of ... the diabetes drug medication Actos (pioglitazone) caused bladder ... 2013, in the U.S. District Court for the Western ... one of thousands of cases pending in the Actos ...
(Date:5/20/2013)... 20, 2013 Mirena IUD lawsuit ... multidistrict litigation recently established in U.S. District Court, Southern ... According to court records, the litigation’s first Status Conference ... to Plaintiff’s leadership positions were discussed. So far, ... Southern District of New York, all of which allege ...
Breaking Medicine News(10 mins):Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Combat Skin Cancer In Summer Months 2Health News:Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 3
... Security Disability Insurance recipients; time-intensive process of receiving benefits can include ... ... Belleville, Ill. (Vocus) June 25, 2008 -- The number ... benefits continued to grow in 2007. This means more people are ...
... of patients admitted to the hospital have alcohol/drug abuse ... sharply in recent years, according to a study in ... Abuse Treatment (JSAT). , "Our results demonstrated ... and the striking financial costs placed on the hospital, ...
... Richer countries perform most, but safety an issue in ... News) -- About 234 million major surgeries are performed ... in high-income countries than in low-income countries, U.S. researchers ... of Public Health, and his colleagues defined major surgeries ...
... TALLAHASSEE, Fla., June 25 Pharmavite, ... has chosen the on-line consumer-centric,program, LearnSomethingAbout(TM), ... Inc. created the engaging, consumer-oriented multimedia,program ... of national retailers., "LearnSomething shares ...
... Mass., June 25 Cynosure, Inc.,(Nasdaq: CYNO ), ... of,light-based aesthetic treatment systems, today announced the opening of ... Located in the Chao,Yang District of Beijing, the office ... sales and marketing for Cynosure China, the company,s,wholly owned ...
... LCA-Vision Inc. (Nasdaq:,LCAV), a leading provider ... brand, is providing an update on the ... for the company,s services., "Macro-economic conditions ... spending, leading to continued softness in,LasikPlus(R) appointments ...
Cached Medicine News:Health News:SSDI Recipients Ask: When Do I Get My Benefits? 2Health News:SSDI Recipients Ask: When Do I Get My Benefits? 3Health News:Study shows high rates, rising costs of alcohol/drug disorders in hospitalized patients 2Health News:Worldwide Surgery Rates Tied to Economic Status 2Health News:Pharmavite Partners With LearnSomething, Inc. on Consumer Education Program, LearnSomethingAbout(TM) 2Health News:Cynosure Expands Presence in China with the Opening of Sales Office in Beijing 2Health News:LCA-Vision Provides Business Update and Market Review 2Health News:LCA-Vision Provides Business Update and Market Review 3Health News:LCA-Vision Provides Business Update and Market Review 4
... tips eliminate false signals and contamination ... tested, Promega Barrier Tips offer performance ... nucleic acids (PCR(a)), radioactive isotopes, tissue ... serological specimens. , Promega Barrier Tips ...
... Finntip Filters are ideal ... amplification methods, or for ... contamination might occur. They ... DNA/RNA solutions, infectious materials, ...
1000 L, Racked, Filtered, Pre-sterilized, 100 tips/rack Recommended for 500 and 1000 L pipettes....
Inquire...
Medicine Products: